CONMED Corp — Director's Dealing 2023

May 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-04-28

Reporting Person: Berge Terence M (VP-Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-28	Common Stock	M	2800	$41.93	Acquired	3804	Direct
2023-04-28	Common Stock	M	5400	$59.96	Acquired	9204	Direct
2023-04-28	Common Stock	M	5400	$78.76	Acquired	14604	Direct
2023-04-28	Common Stock	M	5100	$97.69	Acquired	19704	Direct
2023-04-28	Common Stock	S	2800	$127.44	Disposed	16904	Direct
2023-04-28	Common Stock	S	5400	$126.78	Disposed	11504	Direct
2023-04-28	Common Stock	S	5400	$126.42	Disposed	6104	Direct
2023-04-28	Common Stock	S	5100	$126.65	Disposed	1004	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-28	Options To Purchase Common Stock	$41.93	M	2800	Disposed	2031-03-01	Common Stock (2800)	Direct
2023-04-28	Options To Purchase Common Stock	$59.96	M	5400	Disposed	2028-03-01	Common Stock (5400)	Direct
2023-04-28	Options To Purchase Common Stock	$78.76	M	5400	Disposed	2029-03-01	Common Stock (5400)	Direct
2023-04-28	Options To Purchase Common Stock	$97.69	M	5100	Disposed	2030-03-02	Common Stock (5100)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.25 to $127.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.60 to $127.23. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.54 to $126.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F5: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period